Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Kareclas
Rationale and Study Design of the Adaptive Study of IL-2 Dose on Regulatory T Cells in Type 1 Diabetes (DILT1D): A Non-Randomised, Open Label, Adaptive Dose Finding Trial
BMJ Open
Medicine
Related publications
Adaptive Dose Finding Based Ont-Statistic for Dose–response Trials
Statistics in Medicine
Epidemiology
Statistics
Probability
A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine
British Journal of Cancer
Cancer Research
Oncology
Evaluating Dose Regimens of Apomorphine, an Open-Label Study
International Journal of Impotence Research
Urology
Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials
A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Design of the Myechild Trial, an International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Incorporating an Embedded Dose Finding Study
Trials
Medicine
Pharmacology
Rationale and Study Design for a Randomised Controlled Trial to Reduce Sedentary Time in Adults at Risk of Type 2 Diabetes Mellitus: Project Stand (Sedentary Time ANd Diabetes)
BMC Public Health
Environmental
Public Health
Occupational Health
The Neuroprotection With Statin Therapy for Acute Recovery Trial (Neustart): An Adaptive Design Phase I Dose-Escalation Study of High-Dose Lovastatin in Acute Ischemic Stroke
International Journal of Stroke
Neurology
